The Firm is representing J.P. Morgan Securities LLC and Barclays Bank PLC in connection with $12.5 billion in bridge financing to Thermo Fisher Scientific Inc. in its announced acquisition of Life Technologies Corporation. The proceeds of the bridge facility will be available to finance the acquisition, to repay certain indebtedness of Life Technologies and to pay fees and expenses related thereto.
Thermo Fisher, the world leader in serving science, has approximately 39,000 employees and serves customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. Life Technologies is a global biotechnology company with approximately 10,000 employees and provides innovative products and services to leading customers in the fields of scientific research, genetic analysis and applied sciences.
The Simpson Thacher team includes Patrick Ryan, Ismael Duran and Sam Warfield (Banking and Credit); Art Robinson, Patrick Baron and Kyle Scherer (Capital Markets); Jodi Sackel (Tax); Daniel Avezbaki (Executive Compensation and Employee Benefits); Marcela Robledo (Intellectual Property); and Michael Isby (Environmental).
